From: Correlated levels of cerebrospinal fluid pathogenic proteins in drug-naïve Parkinson’s disease
Patient background | Motor symptoms | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Age | Education | Duration from symptom onset | UPDRS part III | Tremor | Rigidity | Bradykinesia | Gait | Postural instability | ||
Total αS | r | 0.362 | 0.216 | −0.314 | − 0.446* | 0.192 | − 0.331 | − 0.528** | − 0.245 | −0.356 |
p | 0.0635 | 0.2794 | 0.1104 | 0.0289 | 0.3692 | 0.1136 | 0.0080 | 0.2482 | 0.0873 | |
n | 27 | 27 | 27 | 24 | 24 | 24 | 24 | 24 | 24 | |
O-αS | r | 0.010 | −0.036 | 0.203 | −0.205 | 0.265 | − 0.119 | −0.224 | − 0.335 | −0.310 |
p | 0.9614 | 0.8594 | 0.3105 | 0.3356 | 0.2101 | 0.5792 | 0.2928 | 0.1095 | 0.1407 | |
n | 27 | 27 | 27 | 24 | 24 | 24 | 24 | 24 | 24 | |
Aβ1–42 | r | 0.292 | 0.131 | −0.231 | −0.085 | 0.140 | −0.024 | −0.107 | − 0.160 | −0.047 |
p | 0.1389 | 0.5150 | 0.2473 | 0.6913 | 0.5141 | 0.9104 | 0.6203 | 0.4546 | 0.8283 | |
n | 27 | 27 | 27 | 24 | 24 | 24 | 24 | 24 | 24 | |
Total tau | r | 0.334 | 0.180 | −0.212 | −0.297 | 0.002 | −0.195 | −0.426* | − 0.167 | −0.163 |
p | 0.0886 | 0.3702 | 0.2877 | 0.1581 | 0.9934 | 0.3610 | 0.0379 | 0.4346 | 0.4457 | |
n | 27 | 27 | 27 | 24 | 24 | 24 | 24 | 24 | 24 | |
P-tau181p | r | 0.491* | 0.081 | −0.032 | −0.448* | 0.029 | −0.425* | −0.462* | − 0.048 | −0.338 |
p | 0.0126 | 0.7004 | 0.8804 | 0.0365 | 0.8978 | 0.0486 | 0.0303 | 0.8317 | 0.1241 | |
n | 25 | 25 | 25 | 22 | 22 | 22 | 22 | 22 | 22 |